PDCD1 and neoplasm: The modification of CAR-T cells through gene silencing techniques to achieve PD-1 knockout has been mainly studied in vitro, with restricted investigation into the in vivo expansion and anti-tumor characteristics of PD-1 knockout CAR-T cells [74].